Pharmacological anti-inflammatory activity of Lablab purpureus Linn
Clicks: 1
ID: 309170
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #143 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The present study systematically explores the phytochemical and pharmacological potential of Lablab purpureus Linn., with a focus on its anti-inflammatory activity. The anti-inflammatory effect was evaluated using the carrageenan-induced paw oedema model in rats—a well-established biphasic model to assess acute inflammation. Various extracts, including aqueous, methanolic, ethanolic, and chloroform, were administered at different dose levels. Among them, the methanolic extract (MEL) showed the most significant inhibition of oedema, with 200 and 300 mg/kg body weight producing 80% and 82% inhibition, respectively. These effects were superior to those of the standard drug diclofenac, which showed 74% inhibition. Ethyl acetate, aqueous, and chloroform extracts exhibited comparatively lower activity, ranging from 60% to 73% inhibition. Acute toxicity studies confirmed the safety of the methanolic extract up to 2000 mg/kg body weight according to OECD guideline 423. The methanolic extract at 200 mg/kg was selected for further analysis due to its optimal efficacy. Mechanistic studies suggest that MEL inhibits the release of key inflammatory mediators such as histamine, serotonin, and prostaglandins. In vitro assays using LPS-stimulated RAW 264.7 macrophages revealed that MEL significantly suppressed cyclooxygenase (COX) activity and reduced nitric oxide (NO) production, likely via downregulation of inducible nitric oxide synthase (iNOS). Additionally, the extract may inhibit lipoxygenase (LOX) pathways, contributing to decreased leukotriene formation and oxidative stress. These findings indicate that the methanolic extract of Lablab purpureus Linn. possesses potent anti-inflammatory properties and holds promise as a therapeutic agent for the management of acute inflammatory conditions.
| Reference Key |
imported_1761926500_6904dd649b2e5
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | A Vidyadhari, A Bhanumathi, V Sharvanandham, V Shashidhar, V Shirisha, G Rani Priya, M Sudeepa, P Abhiram, P Shireesha |
| Journal | International Journal of Pharmaceutical Drug Design (IJPDD) |
| Year | 2025 |
| DOI |
10.62896/ijpdd.2.5.14
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.